Banexi Ventures Partners  
Search :  
Home page | Contact us | Site map      
     
   

» About us
» Our expertise
» Team
» Portfolio
» News

» Contact us
» Home page


  About us

Banexi Ventures Partners is a French independent managing company. Banexi Ventures Partners invests through Venture Capital Funds, in early stage companies with high growth potential and high technology in 3 different sectors:

  • Internet
  • Electronic
  • Medical Technologies

Banexi Ventures Partners has been operating as BVP team Capital for 14 years :

  • 357 M€ invested since 1983
  • In 254 companies
  • 132 exits M&A (Kelkoo, Inventel,…) or IPO (Soitec, Exonhit, Aden Classified … )

Banexi Ventures Partners has paneuropean investors and some business angels who contribute with their expertise in their specific knowledge area.

Banexi Ventures Partners has a very close relationship with BNP Paribas Group due to its history (spin out).

 

Banexi Ventures Partners is commited to a sustainable investment policy by integrating the ESG (Environmental, Social and Governance) criteria (into their investment strategy).

Several actions have been implemented:
- A chart has been completed by Banexi Ventures Partners and signed by all the members of the team.
- Since October 2011 all new investments of BV5 FCPR complies with our ESG policy: from due diligence process to the lifetime of the investment.

 

 News


Adtech : Adyoulike lève 5 millions de dollars
2016-11-04
    » Read more



Aleva Neurotherapeutics Raises USD 18 Million in Series C Financing Round
2016-05-31
    » Read more



Aleva Neurotherapeutics and Greatbatch, Inc. Collaborate on Next-Generation Device for Deep Brain Stimulation (DBS)
2016-02-02
    » Read more



EYE TECH CARE finalise une levée de fonds de 25 millions d’euros ainsi qu’un partenariat avec EVERPINE Capital
2016-01-15
    » Read more



Stopper le glaucome en une séance d'ultrasons
2015-10-13
    » Read more



VEXIM lance officiellement une étude clinique internationale avec l’inclusion des premiers patients en préparation à sa demande d’autorisation règlementaire 510(k) pour commercialiser le SpineJack® aux États-Unis
2015-06-04
    » Read more



EYE TECH CARE présente sa sonde « nouvelle génération »
2015-05-11
    » Read more







 Discover Portfolio Videos

 

 


 
     
Site web réalisé avec Clic Premium - version 4 / © innovation Partners, tous droits réservés.